XRAY
DENTSPLY SIRONA Inc.
Price Chart
Latest Quote
$10.00
+0.12 (+1.21%)
Current Price
| Previous Close | $9.88 |
| Open | $9.96 |
| Day High | $10.18 |
| Day Low | $9.82 |
| Volume | 3,271,657 |
Stock Information
| Quarterly Dividend / Yield | $0.64 / 5.04% |
| Shares Outstanding | 200.33M |
| Quarterly Dividend Yield | 5.04% |
| Quarterly Dividend | $0.64 |
| Total Debt | $2.34B |
| Cash Equivalents | $190.00M |
| Revenue | $3.68B |
| Net Income | $-628.00M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $2.00B |
| EPS (TTM) | $-3.15 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.16B |
| Sales | $3.68B |
| Income | $-628.00M |
| Book/sh | $6.71 |
| Cash/sh | $0.95 |
| Employees | 14K |
Financial Ratios
| Quick Ratio | 0.67 |
| Current Ratio | 1.53 |
| Debt/Eq | 177.79 |
Returns & Margins
| ROA | 2.26% |
| ROE | -37.67% |
| Gross Margin | 48.93% |
| Operating Margin | 3.41% |
| Profit Margin | -17.06% |
Ownership
| Insider Ownership | 0.46% |
| Institutional Ownership | 110.13% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 6.47 |
| PEG | 0.70 |
| P/S | 0.54 |
| P/B | 1.49 |
Analyst Data
| Recommendation | hold |
| Target Price | $13.40 |
Technical Indicators
| SMA20 | $10.17 |
| SMA50 | $11.14 |
| SMA200 | $12.00 |
| RSI | 48.70 |
| ATR | 0.4800 |
| Shares Float | 199.42M |
| Short Float | 13.19% |
| Short Ratio | 5.00 |
| Volatility | 0.91 |
| Rel Volume | 0.56 |
Performance History
| Week | -4.49% |
| Month | -10.23% |
| Quarter | -21.51% |
| 6 Months | -10.54% |
| YTD | -11.27% |
| Year | -35.52% |
| 3 Years | -69.86% |
| 5 Years | -83.34% |
| 10 Years | -81.59% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $10.00 | 3,469,300 |
| 2026-06-04 | $9.88 | 6,594,200 |
| 2026-06-03 | $9.64 | 3,617,100 |
| 2026-06-02 | $9.83 | 5,958,700 |
| 2026-06-01 | $10.02 | 4,515,400 |
| 2026-05-29 | $10.47 | 7,723,100 |
| 2026-05-28 | $10.29 | 14,375,000 |
| 2026-05-27 | $10.00 | 4,946,500 |
| 2026-05-26 | $9.99 | 5,686,200 |
| 2026-05-22 | $10.21 | 4,783,800 |
| 2026-05-21 | $9.93 | 5,273,600 |
| 2026-05-20 | $9.84 | 6,400,300 |
| 2026-05-19 | $9.74 | 9,690,200 |
| 2026-05-18 | $9.82 | 5,480,400 |
| 2026-05-15 | $10.07 | 9,073,300 |
| 2026-05-14 | $10.41 | 4,407,900 |
| 2026-05-13 | $10.44 | 4,408,100 |
| 2026-05-12 | $11.00 | 4,794,500 |
| 2026-05-11 | $10.91 | 6,231,100 |
| 2026-05-08 | $11.00 | 6,637,800 |
| 2026-05-07 | $10.96 | 6,611,800 |
| 2026-05-06 | $11.14 | 7,958,100 |
About DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
đ° Latest News
1 Cash-Producing Stock with Exciting Potential and 2 We Avoid
StockStory âĸ 2026-06-05T11:36:14Z
Dentsply (XRAY) Down 13.5% Since Last Earnings Report: Can It Rebound?
Zacks âĸ 2026-06-04T15:30:30Z
How Dentsply Sironaâs Expanded Nashville Dental Partnership Could Impact DENTSPLY SIRONA (XRAY) Investors
Simply Wall St. âĸ 2026-05-31T18:04:45Z
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know
StockStory âĸ 2026-05-17T09:40:55Z
The 5 Most Interesting Analyst Questions From Dentsply Sironaâs Q1 Earnings Call
StockStory âĸ 2026-05-15T06:12:55Z
Dentsply Sirona Doubles Down On Digital Dentistry With AI And Wider Reach
Simply Wall St. âĸ 2026-05-10T07:10:25Z
XRAY Stock Down as Q1 Earnings Miss Estimates, Margins Contract
Zacks âĸ 2026-05-06T15:38:00Z
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-06T13:53:45Z
DENTSPLY SIRONA Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-06T04:08:24Z
DENTSPLY SIRONA Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-06T00:17:43Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,840,000,000 | $1,835,000,000 | $1,879,000,000 | $1,795,000,000 |
| Cost Of Revenue | $1,840,000,000 | $1,835,000,000 | $1,879,000,000 | $1,795,000,000 |
| Total Revenue | $3,680,000,000 | $3,793,000,000 | $3,965,000,000 | $3,922,000,000 |
| Operating Revenue | $3,680,000,000 | $3,793,000,000 | $3,965,000,000 | $3,922,000,000 |
| Expenses | ||||
| Interest Expense | $88,000,000 | $69,000,000 | $81,000,000 | $65,000,000 |
| Total Expenses | $3,428,000,000 | $3,605,000,000 | $3,676,000,000 | $3,558,000,000 |
| Other Income Expense | $-650,000,000 | $-1,055,000,000 | $-383,000,000 | $-1,354,000,000 |
| Other Non Operating Income Expenses | $-8,000,000 | $-9,000,000 | $-12,000,000 | $-11,000,000 |
| Net Non Operating Interest Income Expense | $-88,000,000 | $-69,000,000 | $-81,000,000 | $-65,000,000 |
| Interest Expense Non Operating | $88,000,000 | $69,000,000 | $81,000,000 | $65,000,000 |
| Operating Expense | $1,588,000,000 | $1,770,000,000 | $1,797,000,000 | $1,763,000,000 |
| General And Administrative Expense | - | - | $1,620,000,000 | $1,596,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Net Interest Income | $-88,000,000 | $-69,000,000 | $-81,000,000 | $-65,000,000 |
| Normalized Income | $-90,820,000 | $106,712,000 | $147,840,000 | $227,607,000 |
| Net Income From Continuing And Discontinued Operation | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Total Operating Income As Reported | $-422,000,000 | $-879,000,000 | $-85,000,000 | $-937,000,000 |
| Net Income Common Stockholders | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Net Income | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Net Income Including Noncontrolling Interests | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Net Income Continuous Operations | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Pretax Income | $-486,000,000 | $-936,000,000 | $-175,000,000 | $-1,055,000,000 |
| Special Income Charges | $-674,000,000 | $-1,067,000,000 | $-374,000,000 | $-1,301,000,000 |
| Operating Income | $252,000,000 | $188,000,000 | $289,000,000 | $364,000,000 |
| Gross Profit | $1,840,000,000 | $1,958,000,000 | $2,086,000,000 | $2,127,000,000 |
| Earnings From Equity Interest | - | - | $-4,000,000 | $-36,000,000 |
| Per Share | ||||
| Diluted EPS | $-3.00 | $-4.48 | $-0.62 | $-4.41 |
| Basic EPS | $-3.00 | $-4.48 | $-0.62 | $-4.41 |
| Other | ||||
| Tax Effect Of Unusual Items | $-134,820,000 | $-29,288,000 | $-91,160,000 | $-129,393,000 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $596,000,000 | $528,000,000 | $620,000,000 | $645,000,000 |
| Total Unusual Items | $-642,000,000 | $-1,046,000,000 | $-371,000,000 | $-1,307,000,000 |
| Total Unusual Items Excluding Goodwill | $-642,000,000 | $-1,046,000,000 | $-371,000,000 | $-1,307,000,000 |
| Reconciled Depreciation | $352,000,000 | $349,000,000 | $343,000,000 | $328,000,000 |
| EBITDA (Bullshit earnings) | $-46,000,000 | $-518,000,000 | $249,000,000 | $-662,000,000 |
| EBIT | $-398,000,000 | $-867,000,000 | $-94,000,000 | $-990,000,000 |
| Diluted Average Shares | $199,400,000 | $203,200,000 | $212,000,000 | $215,500,000 |
| Basic Average Shares | $199,400,000 | $203,200,000 | $212,000,000 | $215,500,000 |
| Diluted NI Availto Com Stockholders | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Minority Interests | $0 | $0 | $0 | $0 |
| Tax Provision | $112,000,000 | $-26,000,000 | $-43,000,000 | $-105,000,000 |
| Impairment Of Capital Assets | $650,000,000 | $1,014,000,000 | $307,000,000 | $1,287,000,000 |
| Restructuring And Mergern Acquisition | $24,000,000 | $53,000,000 | $67,000,000 | $14,000,000 |
| Gain On Sale Of Security | $32,000,000 | $21,000,000 | $3,000,000 | $-6,000,000 |
| Research And Development | $150,000,000 | $165,000,000 | $184,000,000 | $174,000,000 |
| Selling General And Administration | $1,438,000,000 | $1,605,000,000 | $1,613,000,000 | $1,589,000,000 |
| Gain On Sale Of Business | - | - | $0 | $-3,000,000 |
| Other Gand A | - | - | $1,613,000,000 | $1,589,000,000 |
| Salaries And Wages | - | - | $7,000,000 | $7,000,000 |
Fetched: 2026-06-01
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-783,000,000 | $-862,000,000 | $-850,000,000 | $-780,000,000 |
| Total Assets | $5,429,000,000 | $5,753,000,000 | $7,370,000,000 | $7,643,000,000 |
| Total Non Current Assets | $3,406,000,000 | $4,007,000,000 | $5,397,000,000 | $5,750,000,000 |
| Other Non Current Assets | $284,000,000 | $301,000,000 | $276,000,000 | $198,000,000 |
| Goodwill And Other Intangible Assets | $2,122,000,000 | $2,804,000,000 | $4,143,000,000 | $4,591,000,000 |
| Other Intangible Assets | $974,000,000 | $1,207,000,000 | $1,705,000,000 | $1,903,000,000 |
| Current Assets | $2,023,000,000 | $1,746,000,000 | $1,973,000,000 | $1,893,000,000 |
| Other Current Assets | $150,000,000 | $153,000,000 | $113,000,000 | $88,000,000 |
| Prepaid Assets | $168,000,000 | $151,000,000 | $146,000,000 | $128,000,000 |
| Inventory | $642,000,000 | $564,000,000 | $624,000,000 | $627,000,000 |
| Receivables | $737,000,000 | $606,000,000 | $756,000,000 | $685,000,000 |
| Taxes Receivable | $49,000,000 | $50,000,000 | $61,000,000 | $53,000,000 |
| Accounts Receivable | $688,000,000 | $556,000,000 | $695,000,000 | $632,000,000 |
| Allowance For Doubtful Accounts Receivable | $-12,000,000 | $-14,000,000 | $-17,000,000 | $-14,000,000 |
| Gross Accounts Receivable | $700,000,000 | $570,000,000 | $712,000,000 | $646,000,000 |
| Cash Cash Equivalents And Short Term Investments | $326,000,000 | $272,000,000 | $334,000,000 | $365,000,000 |
| Cash And Cash Equivalents | $326,000,000 | $272,000,000 | $334,000,000 | $365,000,000 |
| Debt | ||||
| Net Debt | $2,002,000,000 | $1,863,000,000 | $1,784,000,000 | $1,579,000,000 |
| Total Debt | $2,468,000,000 | $2,272,000,000 | $2,299,000,000 | $2,147,000,000 |
| Long Term Debt And Capital Lease Obligation | $2,108,000,000 | $1,677,000,000 | $1,921,000,000 | $1,975,000,000 |
| Long Term Debt | $2,015,000,000 | $1,586,000,000 | $1,796,000,000 | $1,826,000,000 |
| Current Debt And Capital Lease Obligation | $360,000,000 | $595,000,000 | $378,000,000 | $172,000,000 |
| Current Debt | $313,000,000 | $549,000,000 | $322,000,000 | $118,000,000 |
| Other Current Borrowings | $231,000,000 | $139,000,000 | $97,000,000 | $23,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $4,089,000,000 | $3,810,000,000 | $4,076,000,000 | $3,831,000,000 |
| Total Non Current Liabilities Net Minority Interest | $2,746,000,000 | $2,221,000,000 | $2,651,000,000 | $2,661,000,000 |
| Other Non Current Liabilities | $544,000,000 | $415,000,000 | $502,000,000 | $399,000,000 |
| Non Current Deferred Liabilities | $94,000,000 | $129,000,000 | $228,000,000 | $287,000,000 |
| Non Current Deferred Taxes Liabilities | $94,000,000 | $129,000,000 | $228,000,000 | $287,000,000 |
| Current Liabilities | $1,343,000,000 | $1,589,000,000 | $1,425,000,000 | $1,170,000,000 |
| Other Current Liabilities | $30,000,000 | $12,000,000 | $18,000,000 | $19,000,000 |
| Current Deferred Liabilities | $74,000,000 | $95,000,000 | $91,000,000 | $84,000,000 |
| Payables And Accrued Expenses | $590,000,000 | $616,000,000 | $787,000,000 | $732,000,000 |
| Interest Payable | $44,000,000 | $8,000,000 | $9,000,000 | $9,000,000 |
| Payables | $330,000,000 | $286,000,000 | $360,000,000 | $331,000,000 |
| Total Tax Payable | $30,000,000 | $45,000,000 | $55,000,000 | $52,000,000 |
| Income Tax Payable | $30,000,000 | $45,000,000 | $49,000,000 | $46,000,000 |
| Accounts Payable | $300,000,000 | $241,000,000 | $305,000,000 | $279,000,000 |
| Equity | ||||
| Common Stock Equity | $1,339,000,000 | $1,942,000,000 | $3,293,000,000 | $3,811,000,000 |
| Total Equity Gross Minority Interest | $1,340,000,000 | $1,943,000,000 | $3,294,000,000 | $3,812,000,000 |
| Stockholders Equity | $1,339,000,000 | $1,942,000,000 | $3,293,000,000 | $3,811,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-639,000,000 | $-730,000,000 | $-636,000,000 | $-628,000,000 |
| Other Equity Adjustments | $-639,000,000 | $-730,000,000 | $-636,000,000 | $-628,000,000 |
| Retained Earnings | $-1,564,000,000 | $-835,000,000 | $205,000,000 | $456,000,000 |
| Other | ||||
| Treasury Shares Number | $64,900,000 | $65,700,000 | $57,300,000 | $49,300,000 |
| Ordinary Shares Number | $199,600,000 | $198,800,000 | $207,200,000 | $215,300,000 |
| Share Issued | $264,500,000 | $264,500,000 | $264,500,000 | $264,600,000 |
| Tangible Book Value | $-783,000,000 | $-862,000,000 | $-850,000,000 | $-780,000,000 |
| Invested Capital | $3,667,000,000 | $4,077,000,000 | $5,411,000,000 | $5,755,000,000 |
| Working Capital | $680,000,000 | $157,000,000 | $548,000,000 | $723,000,000 |
| Capital Lease Obligations | $140,000,000 | $137,000,000 | $181,000,000 | $203,000,000 |
| Total Capitalization | $3,354,000,000 | $3,528,000,000 | $5,089,000,000 | $5,637,000,000 |
| Minority Interest | $1,000,000 | $1,000,000 | $1,000,000 | $1,000,000 |
| Treasury Stock | $3,105,000,000 | $3,136,000,000 | $2,922,000,000 | $2,649,000,000 |
| Additional Paid In Capital | $6,644,000,000 | $6,640,000,000 | $6,643,000,000 | $6,629,000,000 |
| Capital Stock | $3,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Common Stock | $3,000,000 | $3,000,000 | $3,000,000 | $3,000,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $93,000,000 | $91,000,000 | $125,000,000 | $149,000,000 |
| Current Deferred Revenue | $74,000,000 | $95,000,000 | $91,000,000 | $84,000,000 |
| Current Capital Lease Obligation | $47,000,000 | $46,000,000 | $56,000,000 | $54,000,000 |
| Commercial Paper | $82,000,000 | $410,000,000 | $225,000,000 | $95,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $171,000,000 | $155,000,000 | - | - |
| Current Provisions | $118,000,000 | $116,000,000 | $151,000,000 | $163,000,000 |
| Current Accrued Expenses | $260,000,000 | $330,000,000 | $427,000,000 | $401,000,000 |
| Goodwill | $1,148,000,000 | $1,597,000,000 | $2,438,000,000 | $2,688,000,000 |
| Net PPE | $1,000,000,000 | $902,000,000 | $978,000,000 | $961,000,000 |
| Accumulated Depreciation | $-1,572,000,000 | $-1,341,000,000 | $-1,365,000,000 | $-1,312,000,000 |
| Gross PPE | $2,572,000,000 | $2,243,000,000 | $2,343,000,000 | $2,273,000,000 |
| Construction In Progress | $134,000,000 | $87,000,000 | $138,000,000 | $116,000,000 |
| Other Properties | $139,000,000 | $136,000,000 | $178,000,000 | $200,000,000 |
| Machinery Furniture Equipment | $1,609,000,000 | $1,403,000,000 | $1,410,000,000 | $1,363,000,000 |
| Buildings And Improvements | $638,000,000 | $571,000,000 | $568,000,000 | $546,000,000 |
| Land And Improvements | $52,000,000 | $46,000,000 | $49,000,000 | $48,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $361,000,000 | $320,000,000 | $362,000,000 | $381,000,000 |
| Work In Process | $82,000,000 | $72,000,000 | $77,000,000 | $77,000,000 |
| Raw Materials | $199,000,000 | $172,000,000 | $185,000,000 | $169,000,000 |
Fetched: 2026-06-01
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $104,000,000 | $281,000,000 | $228,000,000 | $368,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $235,000,000 | $461,000,000 | $377,000,000 | $517,000,000 |
| Cash Flow From Continuing Operating Activities | $235,000,000 | $461,000,000 | $377,000,000 | $517,000,000 |
| Operating Gains Losses | - | $19,000,000 | $-3,000,000 | $39,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-131,000,000 | $-180,000,000 | $-149,000,000 | $-149,000,000 |
| Investing Cash Flow | $-132,000,000 | $-197,000,000 | $-89,000,000 | $-138,000,000 |
| Cash Flow From Continuing Investing Activities | $-132,000,000 | $-197,000,000 | $-89,000,000 | $-138,000,000 |
| Net Other Investing Changes | $3,000,000 | $-6,000,000 | $8,000,000 | $-2,000,000 |
| Capital Expenditure Reported | $-131,000,000 | $-180,000,000 | $-149,000,000 | $-149,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $-250,000,000 | $-300,000,000 | $-150,000,000 |
| Financing Cash Flow | $-80,000,000 | $-302,000,000 | $-307,000,000 | $-329,000,000 |
| Cash Flow From Continuing Financing Activities | $-80,000,000 | $-302,000,000 | $-307,000,000 | $-329,000,000 |
| Net Other Financing Charges | $-22,000,000 | $-16,000,000 | $-10,000,000 | $-15,000,000 |
| Cash Dividends Paid | $-128,000,000 | $-126,000,000 | $-116,000,000 | $-104,000,000 |
| Net Common Stock Issuance | $0 | $-250,000,000 | $-300,000,000 | $-150,000,000 |
| Common Stock Dividend Paid | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-918,000,000 | $-88,000,000 | $-7,000,000 | $-2,000,000 |
| Issuance Of Debt | $988,000,000 | $178,000,000 | $126,000,000 | $6,000,000 |
| Interest Paid Supplemental Data | $66,000,000 | $91,000,000 | $97,000,000 | $70,000,000 |
| Income Tax Paid Supplemental Data | $71,000,000 | $74,000,000 | $177,000,000 | $122,000,000 |
| End Cash Position | $326,000,000 | $272,000,000 | $334,000,000 | $365,000,000 |
| Beginning Cash Position | $272,000,000 | $334,000,000 | $365,000,000 | $339,000,000 |
| Effect Of Exchange Rate Changes | $31,000,000 | $-24,000,000 | $-12,000,000 | $-24,000,000 |
| Changes In Cash | $23,000,000 | $-38,000,000 | $-19,000,000 | $50,000,000 |
| Common Stock Payments | $0 | $-250,000,000 | $-300,000,000 | $-150,000,000 |
| Net Issuance Payments Of Debt | $70,000,000 | $90,000,000 | $119,000,000 | $-60,000,000 |
| Net Short Term Debt Issuance | $-336,000,000 | $177,000,000 | $126,000,000 | $-64,000,000 |
| Short Term Debt Payments | $-771,000,000 | $0 | $0 | $-64,000,000 |
| Short Term Debt Issuance | $435,000,000 | $177,000,000 | $126,000,000 | - |
| Net Long Term Debt Issuance | $406,000,000 | $-87,000,000 | $-7,000,000 | $4,000,000 |
| Long Term Debt Payments | $-147,000,000 | $-88,000,000 | $-7,000,000 | $-2,000,000 |
| Long Term Debt Issuance | $553,000,000 | $1,000,000 | $0 | $6,000,000 |
| Net Investment Purchase And Sale | $-4,000,000 | $-11,000,000 | $39,000,000 | $13,000,000 |
| Sale Of Investment | $10,000,000 | $1,000,000 | $39,000,000 | $13,000,000 |
| Purchase Of Investment | $-14,000,000 | $-12,000,000 | $0 | $0 |
| Net Business Purchase And Sale | $0 | $0 | $13,000,000 | $0 |
| Sale Of Business | $0 | $0 | $13,000,000 | $0 |
| Change In Working Capital | $-222,000,000 | $95,000,000 | $-56,000,000 | $-78,000,000 |
| Change In Other Working Capital | $-32,000,000 | $38,000,000 | $-11,000,000 | $-15,000,000 |
| Change In Other Current Liabilities | $-5,000,000 | $-28,000,000 | $30,000,000 | $1,000,000 |
| Change In Other Current Assets | $-7,000,000 | $-5,000,000 | $4,000,000 | $1,000,000 |
| Change In Payables And Accrued Expense | $-63,000,000 | $-69,000,000 | $31,000,000 | $24,000,000 |
| Change In Accrued Expense | $-74,000,000 | $-39,000,000 | $17,000,000 | $-6,000,000 |
| Change In Payable | $11,000,000 | $-30,000,000 | $14,000,000 | $30,000,000 |
| Change In Account Payable | $11,000,000 | $-30,000,000 | $14,000,000 | $30,000,000 |
| Change In Prepaid Assets | $-7,000,000 | $38,000,000 | $-58,000,000 | $-33,000,000 |
| Change In Inventory | $-17,000,000 | $17,000,000 | $6,000,000 | $-141,000,000 |
| Change In Receivables | $-91,000,000 | $104,000,000 | $-58,000,000 | $85,000,000 |
| Other Non Cash Items | $-10,000,000 | $-9,000,000 | $2,000,000 | $60,000,000 |
| Stock Based Compensation | $33,000,000 | $39,000,000 | $46,000,000 | $59,000,000 |
| Asset Impairment Charge | $650,000,000 | $1,014,000,000 | $307,000,000 | $1,287,000,000 |
| Deferred Tax | $30,000,000 | $-136,000,000 | $-130,000,000 | $-228,000,000 |
| Deferred Income Tax | $30,000,000 | $-136,000,000 | $-130,000,000 | $-228,000,000 |
| Depreciation Amortization Depletion | $352,000,000 | $349,000,000 | $343,000,000 | $328,000,000 |
| Depreciation And Amortization | $352,000,000 | $349,000,000 | $343,000,000 | $328,000,000 |
| Amortization Cash Flow | $211,000,000 | $216,000,000 | $211,000,000 | $209,000,000 |
| Amortization Of Intangibles | $211,000,000 | $216,000,000 | $211,000,000 | $209,000,000 |
| Depreciation | $141,000,000 | $133,000,000 | $132,000,000 | $119,000,000 |
| Gain Loss On Sale Of PPE | $0 | $19,000,000 | $-3,000,000 | $3,000,000 |
| Net Income From Continuing Operations | $-598,000,000 | $-910,000,000 | $-132,000,000 | $-950,000,000 |
| Earnings Losses From Equity Investments | - | $0 | $4,000,000 | $36,000,000 |
| Proceeds From Stock Option Exercised | - | - | $0 | $6,000,000 |
| Purchase Of Business | - | - | $0 | $0 |
| Net PPE Purchase And Sale | - | - | $7,000,000 | $0 |
| Sale Of PPE | - | - | $7,000,000 | $0 |
| Changes In Account Receivables | - | - | $-58,000,000 | $85,000,000 |
| Gain Loss On Sale Of Business | - | - | $0 | $3,000,000 |
Fetched: 2026-06-01